| Literature DB >> 29725401 |
Sojun Hoshimoto1, Nobuo Hoshi2, Iwao Ozawa1, Moriaki Tomikawa1, Hirofumi Shirakawa1, Takeshi Fujita1, Saho Wakamatsu2, Sayuri Hoshi2, Kaoru Hirabayashi2, Shoichi Hishinuma1, Yoshiro Ogata1.
Abstract
The current study presents the case of a 72-year-old woman with a rapidly enlarged liver metastasis from esophagogastric junction (EGJ) cancer, accompanied by progressive leukocytosis (47,680/µl) and elevated serum granulocyte colony-stimulating factor (G-CSF; 779 pg/ml). The patient underwent right hemihepatectomy 26 months after a total gastrectomy. On the seventh post-operative day the patient's leukocyte count and serum G-CSF level decreased to 4,280/µl and ≤19.5 pg/ml, respectively. Histologically, the lesion was a well to moderately differentiated adenocarcinoma similar to the primary lesion. Therefore, this tumor was clinically diagnosed as a G-CSF-producing liver metastasis from EGJ cancer, although immunohistochemical staining for G-CSF was negative. A right pulmonary nodule detected simultaneously with the hepatic mass was resected four months following the hepatectomy and was diagnosed as a pulmonary metastasis. The patient's leukocyte count was normal at the time of her initial surgery for EGJ cancer, and her clinical course varied for different metastatic sites. The liver metastasis was accompanied by progressive leukocytosis and elevated serum G-CSF and demonstrated rapid tumor growth during a six-month period, whereas the non-G-CSF-producing pulmonary metastasis grew slowly during the same period. In addition 21 reported cases of G-CSF-producing upper gastrointestinal tract cancer were reviewed to elucidate the clinicopathological features of this disease.Entities:
Keywords: esophagogastric junction cancer; granulocyte colony-stimulating factor; leukocytosis; upper gastrointestinal tract cancer
Year: 2018 PMID: 29725401 PMCID: PMC5920498 DOI: 10.3892/ol.2018.8144
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967